Breaking News Instant updates and real-time market news.

2023-01-31 08:17:24 NTAP NetApp $65.50 / +0.05 (+0.08%) 08:17 01/31/23 01/31 08:17 01/31/23 08:17	NetApp to reduce worldwide headcount by approximately 8% In a regulatory filing, on January 31, NetApp announced a plan to restructure and reduce the company's workforce as a part of its planned efforts to realign resources to prioritize investments against its biggest opportunities in light of the macroeconomic challenges and reduced spending environment that continue to impact the company. In connection with these actions, the company expects to reduce its worldwide headcount by approximately 8%. The reduction in workforce is expected to be substantially implemented through the end of the fourth quarter of fiscal 2023. The company expects to incur aggregate charges of approximately $85M-$95M consisting primarily of employee severance and benefit costs associated with the restructuring. The company expects that most of these charges will be cash expenditures and that it will recognize the majority of these charges in the third quarter of fiscal 2023. The estimated charges that the company expects to incur are subject to a number of assumptions, and actual results may differ materially from these estimates. The company may also incur additional costs not currently contemplated due to unanticipated events that may occur as a result of, or that are associated with, its workforce reduction.

2023-01-31 08:17:24

NTAP

NetApp

$65.50 / +0.05 (+0.08%)

08:17

01/31/23

01/31

08:17

01/31/23

08:17

NetApp to reduce worldwide headcount by approximately 8%

In a regulatory filing, on January 31, NetApp announced a plan to restructure and reduce the company's workforce as a part of its planned efforts to realign resources to prioritize investments against its biggest opportunities in light of the macroeconomic challenges and reduced spending environment that continue to impact the company. In connection with these actions, the company expects to reduce its worldwide headcount by approximately 8%. The reduction in workforce is expected to be substantially implemented through the end of the fourth quarter of fiscal 2023. The company expects to incur aggregate charges of approximately $85M-$95M consisting primarily of employee severance and benefit costs associated with the restructuring. The company expects that most of these charges will be cash expenditures and that it will recognize the majority of these charges in the third quarter of fiscal 2023. The estimated charges that the company expects to incur are subject to a number of assumptions, and actual results may differ materially from these estimates. The company may also incur additional costs not currently contemplated due to unanticipated events that may occur as a result of, or that are associated with, its workforce reduction.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Liontown Resources rejects Albemarle's A$2.50 per share proposal » 18:59 03/27/23 03/27 18:59 03/27/23 18:59 LINRF Liontown Resources $1.03 / +0.015 (+1.49%) , ALB Albemarle $218.80 / +1.07 (+0.49%) On March 27, 2023,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ALB ALB Albemarle $218.80 / +1.07 (+0.49%) 03/22/23 Albemarle announces lithium Mega-Flex processing facility in South Carolina 02/23/23 Albemarle raises quarterly dividend to 40c per share 02/22/23 Albemarle signs restructuring and investment agreements with Mineral Resources 01/30/23 Albemarle launches Ketjen, a wholly owned subsidiary LINRF ALB LINRF Liontown Resources $1.03 / +0.015 (+1.49%) 02/06/23 UBS Liontown Resources initiated with a Buy at UBS 01/23/23 JPMorgan Liontown Resources upgraded to Overweight from Neutral at JPMorgan 12/07/22 Goldman Sachs Liontown Resources initiated with a Neutral at Goldman Sachs ALB Albemarle $218.80 / +1.07 (+0.49%) 03/17/23 Loop Capital Albemarle price target raised to $403 from $397 at Loop Capital 03/16/23 Deutsche Bank Deutsche takes 'cautious tone' on lithium stocks near term 03/08/23 Citi Tesla comments 'very bullish' for lithium industry, says Citi 02/21/23 Piper Sandler Albemarle price target raised to $330 from $310 at Piper Sandler ALB ALB Albemarle $218.80 / +1.07 (+0.49%) 02/15/23 Albemarle backs FY23 adjusted EPS view $26.00-$33.00, consensus $28.43 02/15/23 Albemarle reports Q4 adjusted EPS $8.62, consensus $8.28 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 ALB ALB Albemarle $218.80 / +1.07 (+0.49%) 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says ALB ALB Albemarle $218.80 / +1.07 (+0.49%) 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/02/23 Albemarle Corp. ALB ALB Albemarle $218.80 / +1.07 (+0.49%) 02/15/23 Albemarle options imply 4.2% move in share price post-earnings 02/03/23 Unusually active option classes on open February 3rd 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish
Hot Stocks	AnaptysBio 'encouraged' by GSK phase 3 trial results » 18:54 03/27/23 03/27 18:54 03/27/23 18:54 ANAB AnaptysBio $21.89 / +0.48 (+2.24%) , GSK GSK $35.04 / +0.65 (+1.89%) AnaptysBio (ANAB)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ANAB GSK ANAB AnaptysBio $21.89 / +0.48 (+2.24%) 01/13/23 AnaptysBio board authorizes $50M stock repurchase plan 01/05/23 AnaptysBio announces portfolio update, discloses $575M in cash to end 2022 12/02/22 AnaptysBio, GSK announces Phase 3 RUBY trial results for JEMPERLI 11/08/22 AnaptysBio 'well capitalized' to execute with over $590M in cash, says CEO GSK GSK $35.04 / +0.65 (+1.89%) 18:22 Today GSK says Phase III Ruby trial demonstrates Jemperli plus chemotherapy potential 03/24/23 GSK 'respectfully disagrees' with Zantac litigation ruling in California 03/14/23 GSK says MenABCWY combination vaccine candidate met all 11 primary endpoints 03/14/23 GSK reports China NMPA accepts regulatory submission for Nucala ANAB GSK ANAB AnaptysBio $21.89 / +0.48 (+2.24%) 01/06/23 Raymond James AnaptysBio downgraded to Market Perform from Outperform at Raymond James 01/06/23 Raymond James AnaptysBio downgraded to Market Perform from Outperform at Raymond James 11/09/22 Wedbush AnaptysBio price target raised to $32 from $21 at Wedbush 11/01/22 Guggenheim AnaptysBio upgraded to Buy at Guggenheim on checkpoint agonist opportunity GSK GSK $35.04 / +0.65 (+1.89%) 03/17/23 Deutsche Bank GSK upgraded to Buy from Hold at Deutsche Bank 02/26/23 Goldman Sachs GSK reinstated with a Buy at Goldman Sachs 02/10/23 Berenberg GSK price target raised to 1,730 GBp from 1,580 GBp at Berenberg 02/02/23 JPMorgan GSK price target raised to 1,400 GBp from 1,350 GBp at JPMorgan ANAB GSK ANAB AnaptysBio $21.89 / +0.48 (+2.24%) 03/01/23 AnaptysBio reports Q4 EPS (93c), consensus (96c) 11/08/22 AnaptysBio reports Q3 EPS ($1.18), consensus (72c) GSK GSK $35.04 / +0.65 (+1.89%) 02/01/23 GSK reports Q4 adjusted EPS 25.8p vs. 23.6p last year 11/02/22 GSK reports Q3 adjusted EPS 46.9p, up 25% AER, 11% CER GSK GSK GSK $35.04 / +0.65 (+1.89%) 03/01/23 FDA advisers vote 12-0 that data show GSK RSV vaccine effective, Bloomberg says 03/01/23 FDA advisers vote 10-2 that data show GSK RSV vaccine safe, Bloomberg reports 12/30/22 GSK seeks under-appreciated biotechs 'hiding in plain sight', FT reports 12/24/22 Pfizer, Moderna among vaccine makers to watch in 2023, Barron's says ANAB GSK ANAB AnaptysBio $21.89 / +0.48 (+2.24%) 11/03/22 Biotech Alert: Searches spiking for these stocks today GSK GSK $35.04 / +0.65 (+1.89%) 12/30/22 What You Missed On Wall Street On Friday 12/30/22 What You Missed On Wall Street This Morning 12/16/22 Biotech Alert: Searches spiking for these stocks today 12/15/22 Biotech Alert: Searches spiking for these stocks today 05/03/23 PDUFA Date for Arexvy GSK GSK GSK $35.04 / +0.65 (+1.89%) 03/24/23 GSK Pharma put volume heavy and directionally bearish 03/23/23 GSK Pharma call volume above normal and directionally bullish 03/15/23 GSK Pharma call volume above normal and directionally bullish 03/01/23 GSK Pharma put volume heavy and directionally bearish
Hot Stocks	Berkshire Hathaway acquires over 4.4M Occidental shares » 18:52 03/27/23 03/27 18:52 03/27/23 18:52 BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) , BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) , OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BRK.A BRK.B OXY BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) 03/16/23 Berkshire Hathaway buys 7.9M shares of Occidental Petroleum for $466.68M 02/14/23 Berkshire added more of top-holding Apple, Paramount in Q4 12/19/22 Berkshire Hathaway announces Thomas Murphy, Jr. elected to board of directors 12/18/22 Fly Intel: Top five weekend stock stories BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) 03/16/23 Berkshire Hathaway buys 7.9M shares of Occidental Petroleum for $466.68M 02/14/23 Berkshire added more of top-holding Apple, Paramount in Q4 12/19/22 Berkshire Hathaway announces Thomas Murphy, Jr. elected to board of directors 12/18/22 Fly Intel: Top five weekend stock stories OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) 03/16/23 Berkshire Hathaway buys 7.9M shares of Occidental Petroleum for $466.68M 03/07/23 1PointFive, Houston Astros announce direct air capture carbon removal agreement 03/02/23 1PointFive announces plan to develop a carbon capture, sequestration hub 02/28/23 Occidental Petroleum sees FY23 total company production 1.15-1.21Mboed BRK.A BRK.B OXY BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) 03/20/23 Gordon Haskett After rumors, Gordon Haskett suggests Buffett could 'start at home' with Ally 02/26/23 Keefe Bruyette Berkshire price target lowered to $480,000 from $500,000 at Keefe Bruyette 02/07/23 UBS Berkshire can outperform given uncertain economy, says UBS 11/06/22 Keefe Bruyette Berkshire price target lowered to $495,000 from $500,000 at Keefe Bruyette BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) 09/21/22 Edward Jones Berkshire Hathaway upgraded to Buy from Hold at Edward Jones 08/23/22 Gordon Haskett Berkshire largest Celanese holder behind Vanguard, says Gordon Haskett 06/23/22 Truist Truist ups Occidental target to 'Street high' $93, sees good odds of Buffett bid 05/01/22 Keefe Bruyette Berkshire price target lowered to $560,000 from $565,000 at Keefe Bruyette OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) 08:32 Today Morgan Stanley Occidental Petroleum price target lowered to $62 from $71 at Morgan Stanley 03/17/23 Barclays Occidental Petroleum price target raised to $78 from $70 at Barclays 03/10/23 Mizuho Occidental Petroleum price target raised to $83 from $82 at Mizuho 02/22/23 Evercore ISI Occidental Petroleum downgraded to Underperform from In Line at Evercore ISI BRK.A BRK.B OXY BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) 02/26/23 Berkshire Hathaway Q4 operating earnings fall 8%, cash hoard tops $128B 11/05/22 Berkshire Hathaway reports quarterly loss as operating earnings jump 20% BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) 02/26/23 Berkshire Hathaway Q4 operating earnings fall 8%, cash hoard tops $128B 02/25/23 Berkshire Hathaway reports Q4 operating earnings $6.71B vs. $7.29B last year 11/05/22 Berkshire Hathaway reports quarterly loss as operating earnings jump 20% OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) 02/27/23 Occidental Petroleum reports Q4 adjusted EPS $1.61, consensus $1.81 11/08/22 Occidental Petroleum reports Q3 adjusted EPS $2.44, consensus $2.46 BRK.A BRK.B BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 11/20/22 JPMorgan taps Walmart exec for new health venture, Bloomberg says BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 11/20/22 JPMorgan taps Walmart exec for new health venture, Bloomberg says BRK.A BRK.B OXY BRK.A Berkshire Hathaway $458,300.00 / +3677.07 (+0.81%) 03/16/23 Fly Intel: Pre-market Movers 02/27/23 What You Missed On Wall Street On Monday 02/27/23 What You Missed On Wall Street This Morning 11/15/22 What You Missed On Wall Street On Tuesday BRK.B Berkshire Hathaway $302.06 / +3.04 (+1.02%) 02/27/23 What You Missed On Wall Street On Monday 02/27/23 What You Missed On Wall Street This Morning 11/15/22 What You Missed On Wall Street On Tuesday 11/15/22 What You Missed On Wall Street This Morning OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) 03/16/23 Fly Intel: Pre-market Movers 03/13/23 Fly Insider : Uniti Group, AutoNation among week's notable insider trades 02/25/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/22/23 What You Missed On Wall Street On Wednesday 05/05/23 Occidental Petroleum Corporation 05/06/23 Berkshire Hathaway Inc. 05/06/23 Berkshire Hathaway Inc OXY OXY Occidental Petroleum $59.65 / +1.47 (+2.53%) 03/08/23 Early notable gainers among liquid option names on March 8th 03/08/23 Unusually active option classes on open March 8th 02/28/23 Early notable gainers among liquid option names on February 28th 02/27/23 Occidental Petroleum options imply 4.5% move in share price post-earnings
Hot Stocks	GSK says Phase III Ruby trial demonstrates Jemperli plus chemotherapy potential » 18:22 03/27/23 03/27 18:22 03/27/23 18:22 GSK GSK $35.04 / +0.65 (+1.89%) GSK announced interim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GSK $35.04 / +0.65 (+1.89%) 03/24/23 GSK 'respectfully disagrees' with Zantac litigation ruling in California 03/14/23 GSK says MenABCWY combination vaccine candidate met all 11 primary endpoints 03/14/23 GSK reports China NMPA accepts regulatory submission for Nucala 03/01/23 GSK says FDA Advisory Committee supports effectiveness and safety of RSV vaccine GSK GSK $35.04 / +0.65 (+1.89%) 03/17/23 Deutsche Bank GSK upgraded to Buy from Hold at Deutsche Bank 02/26/23 Goldman Sachs GSK reinstated with a Buy at Goldman Sachs 02/10/23 Berenberg GSK price target raised to 1,730 GBp from 1,580 GBp at Berenberg 02/02/23 JPMorgan GSK price target raised to 1,400 GBp from 1,350 GBp at JPMorgan GSK GSK $35.04 / +0.65 (+1.89%) 02/01/23 GSK reports Q4 adjusted EPS 25.8p vs. 23.6p last year 11/02/22 GSK reports Q3 adjusted EPS 46.9p, up 25% AER, 11% CER GSK GSK $35.04 / +0.65 (+1.89%) 03/01/23 FDA advisers vote 12-0 that data show GSK RSV vaccine effective, Bloomberg says 03/01/23 FDA advisers vote 10-2 that data show GSK RSV vaccine safe, Bloomberg reports 12/30/22 GSK seeks under-appreciated biotechs 'hiding in plain sight', FT reports 12/24/22 Pfizer, Moderna among vaccine makers to watch in 2023, Barron's says GSK GSK $35.04 / +0.65 (+1.89%) 12/30/22 What You Missed On Wall Street On Friday 12/30/22 What You Missed On Wall Street This Morning 12/16/22 Biotech Alert: Searches spiking for these stocks today 12/15/22 Biotech Alert: Searches spiking for these stocks today 05/03/23 PDUFA Date for Arexvy GSK GSK $35.04 / +0.65 (+1.89%) 03/24/23 GSK Pharma put volume heavy and directionally bearish 03/23/23 GSK Pharma call volume above normal and directionally bullish 03/15/23 GSK Pharma call volume above normal and directionally bullish 03/01/23 GSK Pharma put volume heavy and directionally bearish
Periodicals	Judge says Amazon must face consumer antitrust suit, Reuters reports » 18:03 03/27/23 03/27 18:03 03/27/23 18:03 AMZN Amazon.com $98.11 / -0.02 (-0.02%) U.S. District Judge… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AMZN Amazon.com $98.11 / -0.02 (-0.02%) 03/24/23 User reports indicate problems at Amazon says Downdetector 03/22/23 Amazon says Fire TV surpasses 200M devices sold globally 03/21/23 Amazon Web Services, Nvidia enter multi-part collaboration for AI infrastructure 03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU AMZN Amazon.com $98.11 / -0.02 (-0.02%) 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/21/23 Loop Capital Best Buy price gap relative to Amazon widens, says Loop Capital 03/21/23 JMP Securities JMP analysis of Amazon data shows Peloton position strengthening 03/21/23 Citi Citi says Amazon becoming more profitable with job cuts AMZN Amazon.com $98.11 / -0.02 (-0.02%) 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 02/02/23 Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c 02/02/23 Notable companies reporting after market close 10/27/22 Amazon sees Q4 revenue $140B-$148B, consensus $155.15B AMZN Amazon.com $98.11 / -0.02 (-0.02%) 03/24/23 Visa offered sweetened $1.4B for Pismo, Valor says 03/23/23 Apple weighs bidding for English football streaming rights, Bloomberg reports 03/20/23 Amazon laying off another 9,000 employees, Bloomberg reports 03/20/23 FTC reviewing Amazon.com's acquisition of iRobot, Politico reports AMZN Amazon.com $98.11 / -0.02 (-0.02%) 03/26/23 Box Office Battle: ‘John Wick: Chapter 4’ opens with huge $73.5M 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/20/23 What You Missed This Week in EVs and Clean Energy AMZN Amazon.com $98.11 / -0.02 (-0.02%) 03/22/23 Notable open interest changes for March 22nd 03/07/23 Notable open interest changes for March 7th 03/03/23 Notable open interest changes for March 3rd 03/03/23 Amazon call buyer realizes 11% same-day gains
Hot Stocks	Tejon Ranch considering options to proceed with development of Centennial » 17:58 03/27/23 03/27 17:58 03/27/23 17:58 TRC Tejon Ranch $18.26 / +0.76 (+4.34%) Los Angeles Superior… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings TRC Tejon Ranch $18.26 / +0.76 (+4.34%) 03/08/23 Tejon Ranch to aggressively pursue commercial/industrial development 11/30/22 Tejon Ranch reports settlement related to Tejon Ranch Conservation agreement TRC Tejon Ranch $18.26 / +0.76 (+4.34%) 03/08/23 Tejon Ranch reports Q4 EPS 7c vs. 13c last year 11/07/22 Tejon Ranch reports Q3 EPS 38c vs 1c last year
On The Fly	Fly Intel: After-Hours Movers » 17:57 03/27/23 03/27 17:57 03/27/23 17:57 PVH PVH Corp. $73.62 / +0.71 (+0.97%) , LYFT Lyft $9.62 / -0.26 (-2.63%) , RAIL FreightCar America $3.17 / + (+0.00%) HIGHER AFTER EARNINGS … Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PVH LYFT RAIL PVH PVH Corp. $73.62 / +0.71 (+0.97%) 16:59 Today PVH Corp. jumps 10% to $80.80 after Q4 results, FY23 guidance beat estimates 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% LYFT Lyft $9.62 / -0.26 (-2.63%) 16:48 Today Lyft announces CEO succession plan, appoints David Risher next CEO 03/14/23 California court upholds treating Uber, Lyft drivers as contractors 02/16/23 Lyft announces Alicia Zuiker joining as Chief People Officer 02/09/23 Lyft says focus on growth will be centered around Pink RAIL FreightCar America $3.17 / + (+0.00%) 03/22/23 North American rail traffic down 6.9% for the week ending March 18 03/15/23 North American rail traffic down 6.1% for the week ending March 11 03/08/23 North American rail traffic down 4.4% for the week ending March 4 03/01/23 North American rail traffic down 3.4% for the week ending February 25 PVH LYFT RAIL PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan LYFT Lyft $9.62 / -0.26 (-2.63%) 03/15/23 Deutsche Bank Lyft price target raised to $12 from $11 at Deutsche Bank 03/14/23 Jefferies California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies 02/14/23 Argus Lyft downgraded to Hold from Buy at Argus 02/14/23 BTIG Lyft downgraded to Neutral from Buy at BTIG RAIL FreightCar America $3.17 / + (+0.00%) PVH LYFT RAIL PVH PVH Corp. $73.62 / +0.71 (+0.97%) 16:17 Today PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92 16:16 Today PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88 16:15 Today PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 LYFT Lyft $9.62 / -0.26 (-2.63%) 02/09/23 Lyft reports Q4 active riders up 8.7% y/y 02/09/23 Lyft sees Q1 revenue roughly $975M, consensus $1.09B 02/09/23 Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year 02/09/23 Notable companies reporting after market close RAIL FreightCar America $3.17 / + (+0.00%) 17:48 Today FreightCar America sees FY23 revenue $400M-$430M 17:48 Today FreightCar America reports Q4 adjusted EPS (31c), two estimates (11c) LYFT LYFT Lyft $9.62 / -0.26 (-2.63%) 16:34 Today Lyft names David Risher CEO, WSJ reports 03/20/23 Uber, Lyft trade group asks Julie Su about view on gig workers, Reuters says 01/26/23 NYC to require Uber and Lyft to be zero emission by 2030, Verge says 01/12/23 Uber drivers struggle to live off their earnings, NY Times reports PVH LYFT PVH PVH Corp. $73.62 / +0.71 (+0.97%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers LYFT Lyft $9.62 / -0.26 (-2.63%) 03/14/23 Fly Intel: Pre-market Movers 02/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 02/10/23 What You Missed On Wall Street This Morning 03/28/23 PVH Corp. - PVH 03/28/23 FreightCar America - RAIL PVH LYFT PVH PVH Corp. $73.62 / +0.71 (+0.97%) 13:04 Today PVH Corp. options imply 5.1% move in share price post-earnings LYFT Lyft $9.62 / -0.26 (-2.63%) 03/17/23 Lyft call volume above normal and directionally bullish 03/10/23 Lyft call volume above normal and directionally bullish 03/08/23 Lyft call volume above normal and directionally bullish 02/21/23 Lyft call volume above normal and directionally bullish
Hot Stocks	TD Synnex names John Henry chief accounting officer » 17:53 03/27/23 03/27 17:53 03/27/23 17:53 SNX TD Synnex $92.97 / +1.455 (+1.59%) According to a regulatory… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SNX TD Synnex $92.97 / +1.455 (+1.59%) 02/28/23 TD Synnex announces partnership with Xcitium 01/10/23 TD Synnex, Authomize partner for ITDR platform 01/10/23 TD Synnex announces $1B share repurchase pact 01/10/23 TD Synnex boosts dividend 17% to 35c per share SNX TD Synnex $92.97 / +1.455 (+1.59%) 02/15/23 Barclays TD Synnex initiated with an Equal Weight at Barclays 01/11/23 Barrington TD Synnex price target raised to $130 from $98 at Barrington 01/11/23 Credit Suisse TD Synnex price target raised to $109 from $103 at Credit Suisse 12/21/22 Citi Citi reveals top IT hardware stock picks for 2023 SNX TD Synnex $92.97 / +1.455 (+1.59%) 01/10/23 TD Synnex sees Q1 EPS $2.60-$3.00, consensus $3.05 01/10/23 TD Synnex reports Q4 EPS $3.44, consensus $2.91 26 Jan SNX TD Synnex $92.97 / +1.455 (+1.59%) 02/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/23 Fly Intel: After-Hours Movers 01/10/23 What You Missed On Wall Street On Tuesday 01/10/23 What You Missed On Wall Street This Morning 03/28/23 TD Synnex - SNX 03/29/23 TD Synnex - SNX
Earnings	StarTek reports Q4 adjusted EPS 35c vs 32c last year » 17:52 03/27/23 03/27 17:52 03/27/23 17:52 SRT StarTek $3.99 / +0.26 (+6.97%) Reports Q4 revenue $92.96… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events SRT StarTek $3.99 / +0.26 (+6.97%) 01/11/23 StarTek enters into definitive agreement to sell interest in CCC 01/10/23 MCI Capital announces results of cash tender offer for shares of StarTek SRT StarTek $3.99 / +0.26 (+6.97%) 11/08/22 StarTek reports Q3 adjusted EPS 10c, consensus 11c 05/18/23 Virtual Spring Investment Conference 17:00 Today StarTek - SRT
Earnings	FreightCar America sees FY23 revenue $400M-$430M » 17:48 03/27/23 03/27 17:48 03/27/23 17:48 RAIL FreightCar America $3.17 / + (+0.00%) Sees FY23 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events RAIL FreightCar America $3.17 / + (+0.00%) 03/22/23 North American rail traffic down 6.9% for the week ending March 18 03/15/23 North American rail traffic down 6.1% for the week ending March 11 03/08/23 North American rail traffic down 4.4% for the week ending March 4 03/01/23 North American rail traffic down 3.4% for the week ending February 25 RAIL FreightCar America $3.17 / + (+0.00%) 17:48 Today FreightCar America reports Q4 adjusted EPS (31c), two estimates (11c) 03/28/23 FreightCar America - RAIL

Earnings	FreightCar America reports Q4 adjusted EPS (31c), two estimates (11c) » 17:48 03/27/23 03/27 17:48 03/27/23 17:48 RAIL FreightCar America $3.17 / + (+0.00%) Reports Q4 revenue $129M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events RAIL FreightCar America $3.17 / + (+0.00%) 03/22/23 North American rail traffic down 6.9% for the week ending March 18 03/15/23 North American rail traffic down 6.1% for the week ending March 11 03/08/23 North American rail traffic down 4.4% for the week ending March 4 03/01/23 North American rail traffic down 3.4% for the week ending February 25 03/28/23 FreightCar America - RAIL
Hot Stocks	Retractable Technologies cuts workforce by roughly 22% » 17:37 03/27/23 03/27 17:37 03/27/23 17:37 RVP Retractable Technologies $1.76 / +0.03 (+1.73%) Retractable Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News RVP Retractable Technologies $1.76 / +0.03 (+1.73%) 12/29/22 Retractable Technologies trading resumes 12/29/22 Retractable Technologies to repurchase 3M shares in private transaction 12/29/22 Retractable Technologies trading halted, news pending 12/15/22 Retractable Technologies reports stock price anomalies
Earnings	Excelerate Energy sees FY23 adjusted EBITDA $320M-$340M 17:37 03/27/23 03/27 17:37 03/27/23 17:37 EE Excelerate Energy $19.71 / +0.77 (+4.07%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events EE Excelerate Energy $19.71 / +0.77 (+4.07%) 03/02/23 Excelerate Energy extends time charter agreement with Dubai Supply Authority 02/28/23 Excelerate Energy signs 20-year sale purchase agreement with Venture Global 11/28/22 Excelerate Energy falls -6.0% 11/09/22 Excelerate Energy raises FY22 adjusted EBITDA view to $264M-$274M EE Excelerate Energy $19.71 / +0.77 (+4.07%) 07/20/22 Barclays Excelerate Energy price target lowered to $27 from $33 at Barclays 07/05/22 Wells Fargo Wells Fargo upgrades Excelerate Energy to Overweight with $29 price target 07/05/22 Wells Fargo Excelerate Energy upgraded to Overweight from Equal Weight at Wells Fargo 05/09/22 Morgan Stanley Excelerate Energy initiated with an Equal Weight at Morgan Stanley EE Excelerate Energy $19.71 / +0.77 (+4.07%) 17:36 Today Excelerate Energy reports Q4 EPS 25c, consensus 22c 11/09/22 Excelerate Energy reports Q3 EPS 34c, consensus 30c 13 Apr 03/28/23 Excelerate Energy - EE
Earnings	Excelerate Energy reports Q4 EPS 25c, consensus 22c » 17:36 03/27/23 03/27 17:36 03/27/23 17:36 EE Excelerate Energy $19.71 / +0.77 (+4.07%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events EE Excelerate Energy $19.71 / +0.77 (+4.07%) 03/02/23 Excelerate Energy extends time charter agreement with Dubai Supply Authority 02/28/23 Excelerate Energy signs 20-year sale purchase agreement with Venture Global 11/28/22 Excelerate Energy falls -6.0% 11/09/22 Excelerate Energy raises FY22 adjusted EBITDA view to $264M-$274M EE Excelerate Energy $19.71 / +0.77 (+4.07%) 07/20/22 Barclays Excelerate Energy price target lowered to $27 from $33 at Barclays 07/05/22 Wells Fargo Wells Fargo upgrades Excelerate Energy to Overweight with $29 price target 07/05/22 Wells Fargo Excelerate Energy upgraded to Overweight from Equal Weight at Wells Fargo 05/09/22 Morgan Stanley Excelerate Energy initiated with an Equal Weight at Morgan Stanley EE Excelerate Energy $19.71 / +0.77 (+4.07%) 11/09/22 Excelerate Energy reports Q3 EPS 34c, consensus 30c 13 Apr 03/28/23 Excelerate Energy - EE
Hot Stocks	Monopar Therapeutics Inc trading resumes 17:30 03/27/23 03/27 17:30 03/27/23 17:30 MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 17:01 Today Monopar completes interim analysis of Phase 2b/3 VOICE trial 16:55 Today Monopar Therapeutics Inc trading halted, news pending 02/27/23 Monopar Therapeutics, NorthStar announces expanded radiopharma program 02/14/23 Monopar Therapeutics announces camsirubicin clinical program update MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 01/23/23 EF Hutton Monopar Therapeutics initiated with a Buy at EF Hutton 12/09/22 Roth Capital Monopar Therapeutics resumed with a Buy at Roth Capital 08/16/22 H.C. Wainwright Monopar Therapeutics price target lowered to $6 from $9 at H.C. Wainwright MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 03/23/23 Monopar Therapeutics reports Q4 EPS (22c), consensus (20c) 11/10/22 Monopar Therapeutics reports Q3 EPS (19c), consensus (22c)
Hot Stocks	Lockheed Martin awarded $210.09M government contract » 17:24 03/27/23 03/27 17:24 03/27/23 17:24 LMT Lockheed Martin $473.25 / -1.11 (-0.23%) Lockheed Martin was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 14:00 Today Aerojet Rocketdyne selected by Lockheed to power additional THAAD interceptors 10:01 Today Lockheed Martin, Singapore's DSTA sign collaboration agreement 03/24/23 Lockheed Martin awarded $186.5M U.S. Navy contract modification 03/24/23 Lockheed Martin awarded $474.2M U.S. Navy contract modification LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 02/21/23 BofA F-35 re-engining an underappreciated opportunity for GE, says BofA 02/06/23 Credit Suisse Lockheed Martin double upgraded to Outperform at Credit Suisse 02/06/23 Credit Suisse Lockheed Martin upgraded to Outperform from Underperform at Credit Suisse 01/30/23 DZ Bank Lockheed Martin upgraded to Buy from Hold at DZ Bank LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 01/24/23 Lockheed Martin reports Q4 adjusted EPS $7.79, consensus $7.39 01/24/23 Lockheed Martin sees FY23 EPS about $26.60-$26.90, consensus $26.93 01/24/23 Lockheed Martin reports Q4 EPS $7.40, consensus $7.39 01/23/23 Notable companies reporting before tomorrow's open LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 03/07/23 Biden to propose Pentagon budget of over $835B, Bloomberg says 01/13/23 Biden administration seeks congressional OK for F-16 sale to Turkey, WSJ says 01/09/23 Canada finalizes deal to buy 88 of Lockheed's F-35 fighter, Reuters reports 01/06/23 McCarthy's speaker deal includes $75B defense cut, Bloomberg reports LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 02/16/23 What You Missed On Wall Street On Thursday 02/16/23 What You Missed On Wall Street This Morning 02/11/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/07/23 What You Missed On Wall Street On Tuesday 03/28/23 Lockheed Martin 04/27/23 Lockheed Martin 04/27/23 Lockheed Martin Corporation LMT Lockheed Martin $473.25 / -1.11 (-0.23%) 02/13/23 Unusually active option classes on open February 13th 01/24/23 Unusually active option classes on open January 24th 11/17/22 Early notable gainers among liquid option names on November 17th 10/18/22 Unusually active option classes on open October 18th
Hot Stocks	Merck reports NRG-GY018 trial shows statistical significance, improvement in PFS » 17:22 03/27/23 03/27 17:22 03/27/23 17:22 MRK Merck $106.95 / +2.11 (+2.01%) Merck announced results… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK Merck $106.95 / +2.11 (+2.01%) 03/16/23 Merck provides update from open-label arm of Phase 2 KeyVibe-002 trial 03/10/23 Merck says Phase 2/3 CCTG IND.227/KEYNOTE-483 trial met primary endpoint 03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 03/06/23 Merck says MK-0616 'significantly reduced' LDL-C in Phase 2b study MRK Merck $106.95 / +2.11 (+2.01%) 03/13/23 Wells Fargo Merck downgraded at Wells Fargo on valuation, lack of catalysts 03/13/23 Wells Fargo Merck downgraded to Equal Weight from Overweight at Wells Fargo 03/10/23 Berenberg Merck price target raised to $130 from $125 at Berenberg 03/09/23 Guggenheim Merck price target raised to $123 from $116 at Guggenheim MRK Merck $106.95 / +2.11 (+2.01%) 02/28/23 NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c) 02/02/23 Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 02/02/23 Merck reports Q4 adjusted EPS $1.62, consensus $1.54 02/01/23 Notable companies reporting before tomorrow's open MRK Merck $106.95 / +2.11 (+2.01%) 02/27/23 Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports MRK Merck $106.95 / +2.11 (+2.01%) 03/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Merck - MRK MRK Merck $106.95 / +2.11 (+2.01%) 03/10/23 Early notable gainers among liquid option names on March 10th 01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th
Syndicate	Syla Technologies 1.875M share IPO expected to price at $8.00 » 17:14 03/27/23 03/27 17:14 03/27/23 17:14 SYT Syla Technologies $92.85 / + (+0.00%) Boustead is acting as… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News SYT Syla Technologies $92.85 / + (+0.00%) 10/03/22 Syngenta, Corteva sued by FTC for pay-to-black scheme
Hot Stocks	Opal Fuels reports Q4 revenue $66.7M, consensus $71.54M » 17:08 03/27/23 03/27 17:08 03/27/23 17:08 OPAL Opal Fuels $7.27 / +0.27 (+3.86%) Reports Q4 production… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options OPAL Opal Fuels $7.27 / +0.27 (+3.86%) 12/13/22 Opal Fuels Inc trading resumes 12/13/22 Opal Fuels Inc trading halted, volatility trading pause OPAL Opal Fuels $7.27 / +0.27 (+3.86%) 02/28/23 Piper Sandler Opal Fuels initiated with Overweight, $12 target at Piper Sandler 02/27/23 Piper Sandler Opal Fuels initiated with an Overweight at Piper Sandler 12/15/22 B. Riley B. Riley starts Opal Fuels with Buy on 'very attractive valuation' 12/15/22 Johnson Rice Opal Fuels initiated with a Buy at Johnson Rice (yesterday) OPAL Opal Fuels $7.27 / +0.27 (+3.86%) 03/01/23 Two new option listings and one option delisting on March 1st
Hot Stocks	Transcat acquires TIC-MS for $9.7M in cash and stock deal » 17:06 03/27/23 03/27 17:06 03/27/23 17:06 TRNS Transcat $88.63 / +1.75 (+2.01%) Transcat announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TRNS Transcat $88.63 / +1.75 (+2.01%) 01/30/23 Transcat says gross margin improvement to continue 10/31/22 Transcat sees FY23 income tax rate 22%-24% 09/28/22 Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M TRNS Transcat $88.63 / +1.75 (+2.01%) 02/02/23 Roth MKM Transcat price target raised to $94 from $80 at Roth Capital 02/01/23 Craig-Hallum Transcat price target raised to $92 from $81 at Craig-Hallum 02/01/23 Northland Transcat price target raised to $100 from $90 at Northland 02/01/23 H.C. Wainwright Transcat price target raised to $96 from $88 at H.C. Wainwright TRNS Transcat $88.63 / +1.75 (+2.01%) 01/30/23 Transcat reports Q3 EPS 35c, consensus 22c 10/31/22 Transcat reports Q2 adjusted EPS 44c, consensus 39c 03/28/23 Transcat

Recommendations	Gamida Cell price target lowered to $8 from $10 at Oppenheimer » 17:03 03/27/23 03/27 17:03 03/27/23 17:03 GMDA Gamida Cell / + Oppenheimer analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GMDA Gamida Cell / + 03/20/23 Gamida Cell board names Shawn Cline Tomasello chairwoman 11/21/22 Gamida Cell says FDA extends omidubicel's PDUFA date to May 1, 2023 11/07/22 Gamida Cell announces preclinical data on GDA-501 09/29/22 Gamida Cell announces long-term data from omidubicel study GMDA Gamida Cell / + 11/15/22 Oppenheimer Gamida Cell price target lowered to $10 from $15 at Oppenheimer 10/02/22 Piper Sandler Piper Sandler keeps Overweight on Gamida Cell, lowers price target to $7 08/15/22 Piper Sandler Gamida Cell price target raised to $8 from $6 at Piper Sandler 08/10/22 H.C. Wainwright H.C. Wainwright a buyer of Gamida Cell ahead of omidubicel PDUFA date GMDA Gamida Cell / + 11/14/22 Gamida Cell reports Q3 EPS (29c), consensus (31c) 28 Sep GMDA Gamida Cell / + 01/11/23 Fly Intel: After-Hours Movers 01/05/23 Biotech Alert: Searches spiking for these stocks today 12/08/22 Biotech Alert: Searches spiking for these stocks today 11/22/22 Fly Intel: Pre-market Movers 08:00 Today Gamida Cell - GMDA 05/01/23 PDUFA Date for Omidubicel - Extended
Hot Stocks	Monopar completes interim analysis of Phase 2b/3 VOICE trial » 17:01 03/27/23 03/27 17:01 03/27/23 17:01 MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) Monopar Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 16:55 Today Monopar Therapeutics Inc trading halted, news pending 02/27/23 Monopar Therapeutics, NorthStar announces expanded radiopharma program 02/14/23 Monopar Therapeutics announces camsirubicin clinical program update 01/26/23 Monopar Therapeutics announces timeline of upcoming data events MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 01/23/23 EF Hutton Monopar Therapeutics initiated with a Buy at EF Hutton 12/09/22 Roth MKM Monopar Therapeutics resumed with a Buy at Roth Capital 08/16/22 H.C. Wainwright Monopar Therapeutics price target lowered to $6 from $9 at H.C. Wainwright MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 03/23/23 Monopar Therapeutics reports Q4 EPS (22c), consensus (20c) 11/10/22 Monopar Therapeutics reports Q3 EPS (19c), consensus (22c)
Hot Stocks	Perma-Pipe International takes steps to expand to Qatar » 17:01 03/27/23 03/27 17:01 03/27/23 17:01 PPIH Perma-Pipe International $10.66 / +0.54 (+5.34%) Perma-Pipe International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News PPIH Perma-Pipe International $10.66 / +0.54 (+5.34%) 03/24/23 Perma-Pipe International announces new plant in Abu Dhabi 03/07/23 Perma-Pipe International awarded $9M+ contract for Winterfell Project 01/06/23 Perma-Pipe International forms JV with Gulf Insulation Group in Saudi Arabia
Hot Stocks	PVH Corp. jumps 10% to $80.80 after Q4 results, FY23 guidance beat estimates 16:59 03/27/23 03/27 16:59 03/27/23 16:59 PVH PVH Corp. $73.62 / +0.71 (+0.97%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% 11/30/22 PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan PVH PVH Corp. $73.62 / +0.71 (+0.97%) 16:17 Today PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92 16:16 Today PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88 16:15 Today PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 PVH PVH Corp. $73.62 / +0.71 (+0.97%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers 03/28/23 PVH Corp. - PVH PVH PVH Corp. $73.62 / +0.71 (+0.97%) 13:04 Today PVH Corp. options imply 5.1% move in share price post-earnings
Hot Stocks	Monopar Therapeutics Inc trading halted, news pending 16:55 03/27/23 03/27 16:55 03/27/23 16:55 MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 02/27/23 Monopar Therapeutics, NorthStar announces expanded radiopharma program 02/14/23 Monopar Therapeutics announces camsirubicin clinical program update 01/26/23 Monopar Therapeutics announces timeline of upcoming data events 01/18/23 Monopar Therapeutics furthers camsirubicin trial past 4th cohort for ASTS MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 01/23/23 EF Hutton Monopar Therapeutics initiated with a Buy at EF Hutton 12/09/22 Roth MKM Monopar Therapeutics resumed with a Buy at Roth Capital 08/16/22 H.C. Wainwright Monopar Therapeutics price target lowered to $6 from $9 at H.C. Wainwright MNPR Monopar Therapeutics $2.90 / -0.09 (-3.01%) 03/23/23 Monopar Therapeutics reports Q4 EPS (22c), consensus (20c) 11/10/22 Monopar Therapeutics reports Q3 EPS (19c), consensus (22c)

Events

Earnings calls, analyst events, roadshows and more

NOAH
Today at 20:00

Noah Holdings - NOAH Conference Calls
HTHT
Today at 21:00

H World Group - HTHT Conference Calls
SPGI
Tomorrow at 00:00

S&P Global - SPGI Conference Calls
BLDE ...
Tomorrow at 00:00

EVTOL Summit Conferences

New York, NY
Tomorrow at 00:00

2023 Enterprise Connect Conference & Expo Conferences

Gaylord Palms, Orlando, FL
CRNX ...
Tomorrow at 00:00

SoCal Biopharma Bus Tour Conferences

San Diego, CA
Tomorrow at 00:00

Shop Talk Conferences

Mandalay Bay, Las Vegas, NV
Tomorrow at 00:00

3rd Annual Pan-European Mid-Cap Conference Conferences

London
Tomorrow at 00:00

US Solar Policy: State of Play, 2023 Outlook & Best Ideas Conferences

New York, NY
Tomorrow at 00:00

Needham Hosted Company Meetings at 2023 Enterprise Connect Conference Conferences

Orlando, FL

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

NetApp to reduce worldwide headcount by approximately 8%

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access